Our Journey

Journey to Excellence

1993

Initial Strides as Relish Pharmaceutical

2012

New management takes over & helps progress

2017

Renaming… birth of Shukra Pharmaceuticals

2019

Shukra's plant make over… complete revamp of the manufacturing set up

2020

Nigeria- NAFDAC renews Shukra manufacturing unit's registration- 1st of many more to follow in quick succession!

2021

Plant approval by Myanmar regulatory body

2021

Vietnam too approves Shukra manufacturing Unit

2022

Approval of Shukra plant by Cambodian authorities

2022

Approval of Shukra plant by Yemen authorities

2022

Shukra Pharma is listed on National Stock Exchange (NSE)

2023

National Drugs Authority, Uganda- approval

2023

Plant registration completed by Malawi authorities

2023

Food & Drugs Administration, Ghana- approval

2023

Approval by Sierra Leone authorities

2023

Pharmacy & Poison Board, Kenya- approval

2024

A 1st for Shukra Pharma - 3 brand registrations in Turkmenistan

Chairman's Message

Breaking Barriers in Healthcare Access

Shukra works with the principle of "Society FIRST". We Manufacture Affordable Generic Medicines. Our products are developed with cutting -edge technology & are meant to provide solutions to the healthcare problems faced by human beings. We are marching towards improved productivity & cost controls. Innovation is a key area of focus at Shukra & we are committed to delivering Quality products from our manufacturing unit. Thus, we are creating a supply chain of quality generic medicines globally.

Worldwide Operations